Finally, since the impaired autophagic signaling was effectively rescued by the p53 inhibition, we performed an experiment to determine whether the molecular and morphological changes that occur in AD brain as well as AD‐related cognitive decline could also be ameliorated with the use of p53 inhibitor. Here, TP53 is linked to Alzheimer disease.